Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

Objective. To evaluate the efficacy and safety of three dosing and repeat treatment regimens of rituximab (RTX) plus MTX in patients with active RA. Methods. Patients with active RA despite stable MTX (10–25 mg/week) were randomly assigned to one of the three treatment regimens comprising two course...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubbert-Roth, Andrea, Tak, Paul P., Zerbini, Cristiano, Tremblay, Jean-Luc, Carreño, Luis, Armstrong, Gillian, Collinson, Neil, Shaw, Tim M.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919195/
https://www.ncbi.nlm.nih.gov/pubmed/20463186
http://dx.doi.org/10.1093/rheumatology/keq116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919195/
https://www.ncbi.nlm.nih.gov/pubmed/20463186
http://dx.doi.org/10.1093/rheumatology/keq116

Ejemplares similares